B3KS15 (B3KS15_HUMAN) Unreviewed, UniProtKB/TrEMBL
Last modified
January 25, 2012.
Version 28.
History...
Names·Attributes·General annotation·Ontologies·Sequences·References·Cross-refs·Entry infoCustomize order
Names·Attributes·General annotation·Ontologies·Sequences·References·Cross-refs·Entry infoCustomize orderNames and origin
| Protein names | Recommended name: 6-phosphofructokinase PIRNR PIRNR000533 EC=2.7.1.11 PIRNR PIRNR000533 Alternative name(s): Phosphohexokinase PIRNR PIRNR000533 |
| Organism | Homo sapiens (Human) EMBL BAG52577.1 |
| Taxonomic identifier | 9606 [NCBI] |
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 776 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at transcript level |
General annotation (Comments)
| Catalytic activity | ATP + D-fructose 6-phosphate = ADP + D-fructose 1,6-bisphosphate. PIRNR PIRNR000533 |
| Pathway | Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 3/4. PIRNR PIRNR000533 |
| Sequence similarities | Belongs to the phosphofructokinase family. Two domains subfamily. PIRNR PIRNR000533 |
Ontologies
| Keywords | |
|---|---|
| Biological process | Glycolysis PIRNR PIRNR000533 |
| Ligand | ATP-binding PIRNR PIRNR000533 RuleBase RU004092 Nucleotide-binding |
| Molecular function | Kinase PIRNR PIRNR000533 RuleBase RU004092 EMBL BAG52577.1 Transferase |
| Gene Ontology (GO) | |
| Biological process | glycolysis Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | 6-phosphofructokinase complex Inferred from electronic annotation. Source: InterPro |
| Molecular function | 6-phosphofructokinase activity Inferred from electronic annotation. Source: EC ATP bindingInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequences
| ||||||||||||||||||
References
| [1] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE. Tissue: Prostate EMBL BAG52577.1. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AK092597 mRNA. Translation: BAG52577.1. |
| IPI | IPI00643196. |
| RefSeq | NP_001229268.1. NM_001242339.1. |
| UniGene | Hs.26010. |
3D structure databases | |
| ProteinModelPortal | B3KS15. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | B3KS15. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| GeneID | 5214. |
| KEGG | hsa:5214. |
Organism-specific databases | |
| CTD | 5214. |
| PharmGKB | PA33217. |
Phylogenomic databases | |
| HOVERGEN | HBG000976. |
Family and domain databases | |
| InterPro | IPR009161. 6-phosphofructokinase_euk. IPR022953. Phosphofructokinase. IPR015912. Phosphofructokinase_CS. IPR000023. Phosphofructokinase_dom. [Graphical view] |
| KO | K00850. |
| Pfam | PF00365. PFK. 2 hits. [Graphical view] |
| PIRSF | PIRSF000533. ATP_PFK_euk. 1 hit. |
| PRINTS | PR00476. PHFRCTKINASE. |
| SUPFAM | SSF53784. Ppfruckinase. 2 hits. |
| TIGRFAMs | TIGR02478. 6PF1K_euk. 1 hit. |
| PROSITE | PS00433. PHOSPHOFRUCTOKINASE. 2 hits. [Graphical view] |
| ProtoNet | Search... |
Entry information
| Entry name | B3KS15_HUMAN | ||||||||
| Accession | Primary (citable) accession number: B3KS15 | ||||||||
| Entry history |
| ||||||||
| Entry status | Unreviewed (UniProtKB/TrEMBL) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||

Clusters with